Research Article
Peer ReviewedAt least two reviewers
Open Access
Nanothermic Systems for Diagnosis and Treatment
1Aksaray University
✉ Corresponding author: Tuğçe Karaduman · tugcekaraduman48@gmail.com
Proceedings 4th International Symposium on Innovative Approaches in Engineering and Natural Sciences
Volume 9 Pages 104–107 Year 2019
References
- J. F. Mongillo, Nanotechnology, 101nd
- Davies, J. C., Managing the Effects of Nanotechnology: Woodrow Wilson International Center for Scholars. Science and Technology Innovation Program, Washington: july. 2006, pen 3.
- M. Kaplan,development of antıbıotıc loaded spacers for two stage total joınt replacement surgery: Department of Nanotechnology and Nanomedicine tez, Hacettepe university, Ankara, Turkey, January 2018.
- (2018) Teknoloji Projeleri website. [Online]. Available: https://teknolojiprojeleri.com/teknik/nanoteknoloji-nedir-ne-ise-yarar-kullanim-alanlari
- D. Sousa, D. Ferreira, Joana L., and Rodrigues Lígia R., Rodrigues, ''Applications of Targeted Nano Drugs and Delivery Systems,'' ScienceDirect Nanoscience and Nanotechnology in Drug Delivery Micro and Nano Technologies., pp. 357-409, 2019.
- Zülfü Tüylek, ''Systems Used in the Field of Nanomedicine'' Archives Medical Review Journal., vol. 28(2), pp. 119-129, 2019.
- C. H. Mastrangelo, ''DNA analysis systems,'' on a chip, Adv. Sci. Technol., vol. 26, pp. 13-465, 1999.
- Zülfü Tüylek, ''Drug Delivery Nanosystems,'' Archives Medical Review Journal., pp. 184-192, 2019.
- Esfand R, Tomalia DA, Beezer AE, Mitchell JC, Hardy M and Orford C. ''Dendripore and dendrilock concepts new controlled delivery strategies,'' Polymer Preprints., vol 41, pp. 2-1324, 2000.
- Kocaefe Ç., ''Yaşam Bilimlerinde Nanoteknoloji Uygulamaları,'' Nanotıp H.Ü. Tıp Dergisi., vol 38(1), pp. 38:33-6, 2007.
- A. Erdoğan, A. Özkan, ''Nanotechnological Applications in Cancer Treatment and Tumor Imaging'' Archives Medical Review Journal., vol. 22(3), pp. 426-440, 2013.
- Y. Dağlıoğlu, H. Özkan Yılmaz and O. Yılmaz ''Nanoparticle Applications in Mammalian Tumor and Normal Cell Lines,'' Archives Medical Review Journal., vol. 27(2), pp. 136-174, 2018.
- Batrakova, E. V., Bronich, T. K., Vetro J.A. and Kabanov, A. V., ''Polymer Micelles as Drug Carriers.'' V. P. Torchilin içinde, Nanoparticulates as Drug Carriers London: Imperial Colloge Press., pp 57-93, 2006.
- Tyrrell ZL, Shen Y and Radosz M., ''Fabrication of micellar nanoparticles for drug delivery through the self-assembly of block copolymers,'' Prog Polym Sci., vol. 35, pp. 43-1128, 2010.
- Groneberg DA, Giersig M, Welte T and Pison U., ''Nanoparticle-based diagnosis and therapy.'' Curr Drug Targets., pp. 7:643-8, 2006.
- Cheng Y, Xu Z, Ma M and Xu T., ''Dendrimers as drug carriers: applications in different routes of drug administration.'' J Pharm Sci., vol. 97, pp. 43-123, January 2008.
- Sahoo, S. K. and Labhasetwar, V., ''Nanotech approaches to drug delivery and imaging.'' Drug discovery today., vol. 8(24) pp. 1112-1120, 2003.
- Sarpa P, Tyagi P and Allen TM., ''Ligand-targeted liposomes for cancer treatment.'' Curr Drug Deliv., pp. 2:369-81, 2005.
- Zhao YZ, Dai DD, Lu CT, Chen LJ, Lin M, Shen XT et al., ''Epirubicin loaded with propylene glycol liposomes significantly overcomes multidrug resistance in breast cancer.'' Cancer Lett., vol. 330, pp. 74-83. 2012.
- Mukherjee S, Ray S and Thakur R., ''Solid lipid nanoparticles: a modern formulation approach in drug delivery system.'' Indian Journal of Pharmaceutical Sciences., pp. 71-349, 2009.
- Le Goff A, Holzinger M and Cosnier S., ''Enzymatic biosensors based on SWCNT-conducting polymer electrodes.,'' Analyst., pp. 136:1279-87, 2011.
- Beg S, Rizwan M, Sheikh AM, Hasnain MS, Anwer K and Kohli K., ''Advancement in carbon nanotubes: basics, biomedical applications and toxicity,'' J Pharm Pharmacol., vol. 63, pp. 63-141, 2011.
- Önyüksel H, Çomoğlu T., ''Nanotaşıyıcılarda Hedeflendirme. Zırh-Gürsoy A. Nanofarmasötikler ve Uygulamaları,'' Kontrollü Salım Sistemleri Derneği, İstanbul., pp. 16-211, 2014.
- Singh R, Lillard J.J.W., ''Nanoparticle Based Drug Delivers,'' Experimental and Molecular Pathology., pp. 9-215, 2009.
Cited by
0 — Crossref — cited-by count (retrieved 2 Oct 2026, source)
Citation counts are shown with their source and retrieval date. They are not an Impact Factor or any journal-level metric.